These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39113268)

  • 1. Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy.
    Boulinguiez A; Dhiab J; Crisol B; Muraine L; Gaut L; Rouxel C; Flaire J; Mouigni HR; Lemaitre M; Giroux B; Audoux L; SaintPierre B; Ferry A; Mouly V; Butler-Browne G; Negroni E; Malerba A; Trollet C
    J Cachexia Sarcopenia Muscle; 2024 Aug; ():. PubMed ID: 39113268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.
    Trollet C; Anvar SY; Venema A; Hargreaves IP; Foster K; Vignaud A; Ferry A; Negroni E; Hourde C; Baraibar MA; 't Hoen PA; Davies JE; Rubinsztein DC; Heales SJ; Mouly V; van der Maarel SM; Butler-Browne G; Raz V; Dickson G
    Hum Mol Genet; 2010 Jun; 19(11):2191-207. PubMed ID: 20207626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin-desmin double knockout (DKO) mouse.
    Moutachi D; Hyzewicz J; Roy P; Lemaitre M; Bachasson D; Amthor H; Ritvos O; Li Z; Furling D; Agbulut O; Ferry A
    J Physiol; 2024 Aug; 602(15):3641-3660. PubMed ID: 38980963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.
    Roth F; Dhiab J; Boulinguiez A; Mouigni HR; Lassche S; Negroni E; Muraine L; Marhic A; Oliver A; Lainé J; Rouche A; O'Ferrall EK; van Engelen B; Ottenheijm C; Greif H; Blumen S; Lacau St Guily J; Perie S; Butler-Browne G; Mouly V; Trollet C
    Acta Neuropathol; 2022 Dec; 144(6):1157-1170. PubMed ID: 36197469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD).
    Harish P; Malerba A; Lu-Nguyen N; Forrest L; Cappellari O; Roth F; Trollet C; Popplewell L; Dickson G
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1016-1026. PubMed ID: 31066242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.
    Vest KE; Phillips BL; Banerjee A; Apponi LH; Dammer EB; Xu W; Zheng D; Yu J; Tian B; Pavlath GK; Corbett AH
    Hum Mol Genet; 2017 Sep; 26(17):3235-3252. PubMed ID: 28575395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharyngeal pathology in a mouse model of oculopharyngeal muscular dystrophy is associated with impaired basal autophagy in myoblasts.
    Zhang Y; Zeuthen C; Zhu C; Wu F; Mezzell AT; Whitlow TJ; Choo HJ; Vest KE
    Front Cell Dev Biol; 2022; 10():986930. PubMed ID: 36313551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1.
    Malerba A; Klein P; Lu-Nguyen N; Cappellari O; Strings-Ufombah V; Harbaran S; Roelvink P; Suhy D; Trollet C; Dickson G
    Hum Mol Genet; 2019 Oct; 28(19):3301-3308. PubMed ID: 31294444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Myostatin Reduces Collagen Deposition in a Mouse Model of Oculopharyngeal Muscular Dystrophy (OPMD) With Established Disease.
    Harish P; Forrest L; Herath S; Dickson G; Malerba A; Popplewell L
    Front Physiol; 2020; 11():184. PubMed ID: 32194441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy.
    Raz V; Sterrenburg E; Routledge S; Venema A; van der Sluijs BM; Trollet C; Dickson G; van Engelen BG; van der Maarel SM; Antoniou MN
    BMC Neurol; 2013 Jul; 13():70. PubMed ID: 23815790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.
    Gidaro T; Negroni E; Perié S; Mirabella M; Lainé J; Lacau St Guily J; Butler-Browne G; Mouly V; Trollet C
    J Neuropathol Exp Neurol; 2013 Mar; 72(3):234-43. PubMed ID: 23399899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oculopharyngeal muscular dystrophy as a paradigm for muscle aging.
    Raz Y; Raz V
    Front Aging Neurosci; 2014; 6():317. PubMed ID: 25426070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.
    García-Castañeda M; Vega AV; Rodríguez R; Montiel-Jaen MG; Cisneros B; Zarain-Herzberg A; Avila G
    J Physiol; 2017 Jul; 595(13):4167-4187. PubMed ID: 28303574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging.
    Anvar SY; Raz Y; Verway N; van der Sluijs B; Venema A; Goeman JJ; Vissing J; van der Maarel SM; 't Hoen PA; van Engelen BG; Raz V
    Aging (Albany NY); 2013 Jun; 5(6):412-26. PubMed ID: 23793615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
    van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
    J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PABPN1 gene therapy for oculopharyngeal muscular dystrophy.
    Malerba A; Klein P; Bachtarzi H; Jarmin SA; Cordova G; Ferry A; Strings V; Espinoza MP; Mamchaoui K; Blumen SC; St Guily JL; Mouly V; Graham M; Butler-Browne G; Suhy DA; Trollet C; Dickson G
    Nat Commun; 2017 Mar; 8():14848. PubMed ID: 28361972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PABPN1 loss-of-function causes APA-shift in oculopharyngeal muscular dystrophy.
    Shademan M; Mei H; van Engelen B; Ariyurek Y; Kloet S; Raz V
    HGG Adv; 2024 Apr; 5(2):100269. PubMed ID: 38213032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy.
    Davies JE; Rubinsztein DC
    Hum Mol Genet; 2011 Mar; 20(6):1154-63. PubMed ID: 21199860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of
    Cruz-Aguilar M; Guerrero-de Ferran C; Tovilla-Canales JL; Nava-Castañeda A; Zenteno JC
    J Investig Med; 2017 Mar; 65(3):705-708. PubMed ID: 27980005
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.